Susquehanna International Group’s Microbot Medical MBOT Stock Holding History

Susquehanna International Group’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.6K	Buy	+12,300	New	+$27.5K	﹤0.01%	12767
2025 Q4	–	Sell	-10,200	Closed	-$31.1K	–	13082
2025 Q3	$31.1K	Sell	10,200 -281,200	-96%	-$877K	﹤0.01%	11973
2025 Q2	$734K	Buy	291,400 +216,500	+289%	+$518K	﹤0.01%	8233
2025 Q1	$113K	Buy	+74,900	New	+$132K	﹤0.01%	11457
2024 Q1	–	Sell	-10,000	Closed	-$16.4K	–	12853
2023 Q4	$16.4K	Sell	10,000 -1,100	-10%	-$1.47K	﹤0.01%	12004
2023 Q3	$15.4K	Buy	+11,100	New	+$24.1K	﹤0.01%	11659

Other funds holding MBOT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group's MBOT Position: Q1 2026 in Review

Susquehanna International Group reduced its Microbot Medical (MBOT) stake by 26% in Q1 2026, selling an estimated $717K and leaving 924,307 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #5926.

Susquehanna International Group first reported a position in MBOT in Q3 2014 and has held it in 10 quarters since. The position peaked at $3.81M in Q3 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

Susquehanna International Group held 924,307 shares of Microbot Medical worth $2.23M as of Q1 2026.
Susquehanna International Group sold 320,816 Microbot Medical shares in Q1 2026, an estimated $717K.
Microbot Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5926 holding.
Susquehanna International Group first reported a position in Microbot Medical in Q3 2014 and has held it in 10 quarters since.
Susquehanna International Group's Microbot Medical position peaked at $3.81M in Q3 2025.
79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.